Erythema multiforme during GM-CSF therapy.
DOI:
https://doi.org/10.2340/0001555574135137Abstract
A 52-year-old Caucasian man treated with granulocyte-macrophage colonystimulating factor (GM-CSF) developed a cutaneous eruption on legs and ankles with clinical and histologic features of erythema multiforme. Laboratory studies indicated that the eruption occurred at the time of peripheral blood lymphocyte recovery and that it was coincidental with serum peaks of interleukin-1 (IL-1), interleukin-2 (IL-2), interleukin-6 (IL-6) and tumour necrosis factor-alpha. We postulate that GM-CSF provoked erythema multiforme in a predisposed individual as a consequence of either an inappropriate cytokine secretion or of an abnormal amplification mechanism following lymphocyte recovery.Downloads
Download data is not yet available.
Downloads
Published
1994-03-01
How to Cite
Stasi, R., Gatti, S., Perrotti, A., Orlandi, A., Spagnoli, L. G., & Papa, G. (1994). Erythema multiforme during GM-CSF therapy. Acta Dermato-Venereologica, 74(2), 132–134. https://doi.org/10.2340/0001555574135137
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
